Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBHRD.L Regulatory News (BHRD)

  • There is currently no data for BHRD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Be Heard Group plc

23 Jun 2020 10:45

RNS Number : 7985Q
MSQ Partners Limited
23 June 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MSQ Partners Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Ensco 1314 Limited, itself owned and controlled by Directors of MSQ Partners and LDC

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Be Heard Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

22 June 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

None

None

None

None

(2) Cash-settled derivatives:

 

None

None

None

None

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

None

None

None

None

 

TOTAL:

None

None

None

None

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests of concert party members in Be Heard Group plc's ordinary shares of 1 pence each:

 

Name

Be Heard Ordinary Shares

Percentage of Be Heard issued share capital

Richard Armstrong

73,322,549

5.88%

Ben Rudman

69,726,942

5.59%

James Cannings

69,726,942

5.59%

Peter Robins

59,040,542

4.74%

Rhys Williams

51,878,974

4.16%

Neil Hourston

46,924,363

3.76%

Neil Simpson

46,924,363

3.76%

Tom Ewart

46,924,363

3.76%

Mark Starling

12,130,361

0.97%

Nick Bygate

10,977,861

0.88%

Stephen Dover

9,040,453

0.73%

Rob Yardy

4,912,665

0.39%

Andrzej Moyseowicz

4,651,883

0.37%

Christopher Palengat

4,651,883

0.37%

Rohan Desai

4,591,385

0.37%

Yasser Abbasi

3,608,862

0.29%

Ian Stanton

3,438,913

0.28%

 

 

 

(b) Be Heard Group plc Performance Share Plan Awards granted to members of the concert party:

 

 

Name

Date of grant

Number of ordinary shares of 1 pence each subject to the outstanding awards

Exercise price per ordinary share(1)

Vesting Date(1)

Ben Rudman

13-May-19

25,000,000

Nil

N/A

 

(1) The remuneration committee of the Company, exercising its pre-existing discretion, has resolved not to exercise these awards as the relevant performance conditions have not and will not be met. As a result, the LTIP Award granted to Ben Rudman will not vest and will not become exercisable in connection with the offer.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

23 June 2020

Contact name:

Richard Darlington / Dan Bate

(Zeus Capital)

 

Telephone number:

0161 831 1512

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEESESSUDESSELM
Date   Source Headline
4th Jun 20197:00 amRNSNew Client Wins and Issue of Shares
15th May 201912:46 pmRNSResult of Annual General Meeting
15th May 20197:00 amRNSAGM Statement
18th Apr 20193:33 pmRNSNotice of Annual General Meeting
4th Apr 201910:28 amRNSHolding(s) in Company
26th Mar 20197:59 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results For The Year Ended 31 December 2018
18th Mar 20192:27 pmRNSHolding(s) in Company
14th Jan 20197:00 amRNSPre-close trading update
29th Nov 20182:44 pmRNSHolding(s) in Company
23rd Nov 20184:37 pmRNSDirector/PDMR Shareholding
1st Nov 20185:53 pmRNSDirector/PDMR Shareholding
28th Sep 20184:15 pmRNSDirector/PDMR Shareholding
28th Sep 20184:13 pmRNSDirector/PDMR Shareholding
20th Sep 20185:45 pmRNSDirector/PDMR Shareholding
20th Sep 20184:16 pmRNSCorrection: Director/PDMR Shareholding
20th Sep 20182:50 pmRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSHalf-year Report
4th Sep 20182:00 pmRNSBoard Changes
6th Aug 20187:00 amRNSDirectorate Change
19th Jul 20182:05 pmRNSSecond Price Monitoring Extn
19th Jul 20182:00 pmRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSPre-close trading update
16th Jul 20185:23 pmRNSHolding(s) in Company
22nd May 20183:48 pmRNSAGM Statement
1st May 20185:00 pmRNSTotal Voting Rights
18th Apr 20184:08 pmRNSIssue of Shares - Replacement
18th Apr 20188:00 amRNSIssue of Shares
18th Apr 20187:00 amRNSFinal Results
27th Mar 20187:00 amRNSBoard changes
15th Mar 20187:00 amRNSNotice of Results
20th Feb 20189:07 amRNSDirector/PDMR Shareholding
6th Feb 20184:37 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSTrading Update and Board Changes
15th Dec 20172:51 pmRNSUpdate on progress at Kameleon
7th Dec 201712:20 pmRNSNotice of Board resignation
29th Nov 20171:56 pmRNSHolding(s) in Company
29th Nov 20171:55 pmRNSDirector/PDMR Shareholding
28th Nov 20177:00 amRNSResult of General Meeting
10th Nov 20178:02 amRNSResults of Placing
9th Nov 20174:51 pmRNSReplacement: Proposed Fundraising
9th Nov 20174:35 pmRNSAcquisition of The Corner
18th Oct 20177:00 amRNSContract win with Addison Lee
9th Oct 20175:15 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSHalf-year Results
5th Sep 201710:50 amRNSNotice of Results
25th Aug 20177:00 amRNSRevision to MMT Limited earn out arrangements
3rd Aug 20178:00 amRNSBe Heard Partners and Vodafone Microsite Launch
2nd Aug 20177:00 amRNSAppointment of Non-Executive Director
2nd Aug 20177:00 amRNSStrong revenue growth in first half

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.